Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD)

Molecular Psychiatry

Volumn 5, Issue 5, 2000, Pages 537-541

  Quist, J F ^a   Barr, C L ^b   Schachar, R ^c   Roberts, W ^c   Malone, M ^c   Tannock, R ^c   Basile, V S ^a   Beitchman, J ^c   Kennedy, J L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ADHD; Genetics; HTR2A; Linkage disequilibrium; Serotonin; TDT

Indexed keywords

SEROTONIN 2A RECEPTOR;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; DNA POLYMORPHISM; DOPAMINE RELEASE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SCHOOL CHILD; SEROTONINERGIC TRANSMISSION;

EID: 0033799317     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000779     Document Type: Article

References (46)

1. Role of serotonin in the paradoxical calming effect of psycho-stimulants on hyperactivity
2. Neurobiology of attention-deficit hyper-activity disorder
3. Serotonergic modulation of midbrain dopamine systems
4. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children
5. Serotonin concentrations in whole blood of hyperactive children
6. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder
7. Treatment of ADHD with fluoxetine: A preliminary trial
8. Selegiline in ADHD adults: Plasma monoamines and monoamine metabolites
9. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents
10. A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders. Prediction by cerebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and autonomic measures?
11. Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder
12. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder
13. Neuroendocrine response to fenfluramine challenge in boys. Associations with aggressive behavior and adverse rearing
14. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task
15. A family study of patients with attention deficit disorder and normal controls
16. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder
17. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples
18. Genetic basis of attention deficit and hyperactivity
19. Families of children with attention deficit hyperactivity disorder: A review
20. Association of attention-deficit disorder and the dopamine transporter gene
21. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
22. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
23. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity
24. The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14
25. A review of central 5-HT receptors and their function
26. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB
27. Two naturally occurring amino acid substitutions of the 5-HT2A receptor: Similar prevalence in patients with seasonal affective disorder and controls
28. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
29. An MspI polymorphism in the human serotonin receptor gene (HTR2): Detection by DGGE and RFLP analysis
30. A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization
31. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
32. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
33. Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist
34. Serotonin-dopamine interaction and its relevance to schizophrenia
35. Evaluation of the revised Ontario Child Health Study scales
36. A simple salting out procedure for extracting DNA from human nucleated cells
37. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci
38. Transmission/disequilibrium tests for extended marker haplotypes